type 4 vaccine to military recruits has resulted in a gratifying reduction in the incidence of specific adenoviral acute respiratory disease (ARD) [1-4]. The vaccine elicits an immune response in vaccinees, and when used as a mass immunization, it also decreased ARD in nonvaccinated contacts [5]. Administration of the live virus orally, as an enteric-coated capsule or tablet, apparently permits bypass of the pharynx with selective infection of the intestine [6], The vaccine strain was not prepared by attenuation of virulence, but the intestinal infection is asymptomatic and has caused no adverse effects [5-7]. Most vaccinees shed virus in the stool repeatedly during the period 2-3 weeks after virus ingestion. In spite of this proliferation and excretion of infectious virus, no evidence was found among military personnel for spread of the virus to contacts living in the same barracks and sharing common table and toilet facilities [1, 8]. In the studies reported here, the question of the propensity for spread of the live adenovirus type 4 vaccine strain was investigated in another setting. In 2 studies, 1 member of 39 civilian married, childless couples was vaccinated. Both virologic and serologic evidence of spread between partners was obtained.